--- title: "04:49 ETPROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT" type: "News" locale: "en" url: "https://longbridge.com/en/news/293903794.md" description: "The DJS Law Group is reminding investors of a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) for alleged violations of federal securities laws. The complaint alleges the company made false statements by inflating revenue through aggressive discounting, creating market inventory gluts. Shareholders who purchased shares between February 28, 2024, and February 25, 2026, are encouraged to contact the firm regarding lead plaintiff appointments or potential recovery by the September 22, 2026 deadline." datetime: "2026-07-27T08:49:24.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293903794.md) - [en](https://longbridge.com/en/news/293903794.md) - [zh-HK](https://longbridge.com/zh-HK/news/293903794.md) generator: "portal-rs" --- # 04:49 ETPROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT , /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT) violations of ยงยง10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of PRCT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. **CLASS PERIOD:** February 28, 2024 to February 25, 2026 **DEADLINE:** September 22, 2026 **CASE DETAILS:** According to the Complaint, the Company made false and misleading statements to the market. Procept inflated its revenue by using aggressive discounting to pull sales forward from future periods. The Company's discounting policy created a glut of inventory in the market. Based on these facts, Procept's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate. **WHY DJS LAW GROUP?** DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. **CONTACT:** David J. Schwartz DJS Law Group 274 White Plains Road, Suite 1 Eastchester, NY 10709 Phone: 914-206-9742 Email: \[email protected\] SOURCE DJS Law Group LLP ### Related Stocks - [PRCT.US](https://longbridge.com/en/quote/PRCT.US.md) ## Related News & Research - [PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit](https://longbridge.com/en/news/296500440.md) - [04:35 ETPROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT](https://longbridge.com/en/news/296589247.md) - [10:06 ETPRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit](https://longbridge.com/en/news/296026209.md) - [03:03 ETPlanet Fitness, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PLNT](https://longbridge.com/en/news/296066825.md) - [14:07 ETPROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/296135378.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**